发明授权
US08153799B2 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
有权
氮杂双环氨基甲酸酯及其作为α-7烟碱乙酰胆碱受体激动剂的用途
- 专利标题： Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
- 专利标题（中）： 氮杂双环氨基甲酸酯及其作为α-7烟碱乙酰胆碱受体激动剂的用途
-
申请号： US12871495申请日： 2010-08-30
-
公开(公告)号： US08153799B2公开(公告)日： 2012-04-10
- 发明人: Timo Flessner , Frank-Gerhard Boss , Christina Erb , Frank-Thorsten Hafner , Katrin Schnizler , Dieter Lang , Joachim Luithle , Marja Van Kampen , Franz-Josef Van Der Staay
- 申请人： Timo Flessner , Frank-Gerhard Boss , Christina Erb , Frank-Thorsten Hafner , Katrin Schnizler , Dieter Lang , Joachim Luithle , Marja Van Kampen , Franz-Josef Van Der Staay
- 申请人地址： DE Berlin
- 专利权人： Bayer Schering Pharma Aktiengesellschaft
- 当前专利权人： Bayer Schering Pharma Aktiengesellschaft
- 当前专利权人地址： DE Berlin
- 代理机构： Edwards Wildman Palmer LLP
- 代理商 Ralph A. Loren; Nicholas J. DiCeglie, Jr.
- 优先权： DE10234424 20020729
- 主分类号： C07D453/02
- IPC分类号： C07D453/02 ; C07D307/00
摘要：
The invention relates to novel benzothiophene-, benzofuran-, and indole ureas and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning, and/or memory.